Development asset linked to iQure Pharma in public FDA and regional records.
biotech · Huntington’s Disease · Amyotrophic Lateral Sclerosis (ALS)
iQure Pharma
uniQure biopharma B.V.
iQure Pharma drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Princeton, USA HQ
2019 Founded
9 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Princeton, USA
- Founded
- 2019
- Employees
- 9
- Programs
- 2
- Drugs
- 2
- Patents
- 0
iQure Pharma pipeline
Portfolio lens on 2 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
iQure Pharma drug portfolio — 2 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to iQure Pharma in public FDA and regional records.